Histamine antilipolytic action in rat adipocytes: comparison with the effect of tyramine.
Meissonnier
G
G
U317 INSERM, IFR 31, Bat. L3, CHU Rangueil, 31403 Toulouse, France.
Heniquez
A
A
Visentin
V
V
Prévot
D
D
Carpéné
C
C
D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism*; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014439:Tyramine / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D001596:Benzylamines; D007004:Hypoglycemic Agents; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D006632:Histamine; D010293:Pargyline; C030796:benzylamine; D007545:Isoproterenol; D014439:Tyramine